Your browser doesn't support javascript.
loading
A New Series of Indeno[1,2-c]pyrazoles as EGFR TK Inhibitors for NSCLC Therapy.
Özdemir, Ahmet; Ciftci, Halilibrahim; Sever, Belgin; Tateishi, Hiroshi; Otsuka, Masami; Fujita, Mikako; Altintop, Mehlika Dilek.
Affiliation
  • Özdemir A; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskisehir 26470, Turkey.
  • Ciftci H; Department of Drug Discovery, Science Farm Ltd., Kumamoto 862-0976, Japan.
  • Sever B; Medicinal and Biological Chemistry Science Farm Joint Research Laboratory, Faculty of Life Sciences, Kumamoto University, Kumamoto 862-0973, Japan.
  • Tateishi H; Department of Molecular Biology and Genetics, Koc University, Istanbul 34450, Turkey.
  • Otsuka M; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskisehir 26470, Turkey.
  • Fujita M; Medicinal and Biological Chemistry Science Farm Joint Research Laboratory, Faculty of Life Sciences, Kumamoto University, Kumamoto 862-0973, Japan.
  • Altintop MD; Medicinal and Biological Chemistry Science Farm Joint Research Laboratory, Faculty of Life Sciences, Kumamoto University, Kumamoto 862-0973, Japan.
Molecules ; 27(2)2022 Jan 13.
Article in En | MEDLINE | ID: mdl-35056800
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pyrazoles / Protein-Tyrosine Kinases / Carcinoma, Non-Small-Cell Lung / Protein Kinase Inhibitors / Lung Neoplasms / Antineoplastic Agents Type of study: Prognostic_studies Limits: Humans Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pyrazoles / Protein-Tyrosine Kinases / Carcinoma, Non-Small-Cell Lung / Protein Kinase Inhibitors / Lung Neoplasms / Antineoplastic Agents Type of study: Prognostic_studies Limits: Humans Language: En Year: 2022 Type: Article